Reminder - Webcast/Conference Call to Discuss Fantastic PRIME Phase 1b Top-line Data
-
Legendary Cuban spy chief Ramiro Valdes dies at 94
-
Yamal off the mark at World Cup as Spain thrash Saudi Arabia
-
Clark and Scheffler begin final-round drama at US Open
-
Yamal off mark at World Cup as Spain thrash Saudi
-
Yamal scores on injury return as Spain thrash Saudi Arabia
-
Noskova overpowers Pegula to win Berlin WTA
-
Iran warns US to 'be careful' after Trump threat
-
Gakpo savours 'freedom' to fire Dutch in World Cup title bid
-
Cerundolo outlasts Paul to win marathon Queen's Club final
-
Pogacar wins final stage to seal Tour of Switzerland success
-
Henry the hero for New Zealand as England bring back Stokes
-
Bolivia removes roadblocks after emergency decree
-
Vance hopes US, Iran can turn 'new leaf' with talks
-
Europe sweats through new heatwave, with worse to come
-
Trump-backed hardliner faces leftist senator as Colombia votes
-
Japan striker Ueda channels frustration to send World Cup warning
-
Dominant Tiafoe swats aside Fritz to win Halle Open
-
France hosts street music festival despite worsening heatwave
-
India hails Sooryavanshi after record 11-ball half-century
-
Swiss US-Iran talks venue a playground of world leaders, movie stars
-
Yamal returns to kickstart Spain attack against Saudi Arabia
-
Colombians vote in presidential runoff
-
Nigerian twins Taiwo and Kehinde marry... Taiwo and Kehinde
-
Marc Marquez wins Czech MotoGP to close gap on banned Bezzecchi
-
France presses ahead with street music festival despite extreme heat
-
Marc Marquez wins Czech MotoGP as Bezzecchi banned
-
'Historical justice': Dutch PM makes formal apology to Moluccans
-
Stokes to return as England captain for 3rd New Zealand Test - McCullum
-
Henry the hero as New Zealand level England series in style
-
Britain's King Charles to reveal personal tax bill: Palace
-
Gill to skipper India against England, Kohli to play if fit
-
France presses ahead with street music festivals despite extreme heat
-
UK's Starmer mulling 'political realities': senior minister
-
England's Stokes and Atkinson withdrawn from county games ahead of 3rd Test
-
France presses ahead with music festivals despite extreme heat
-
Ukrainian strikes on Russian-annexed Crimea kill 4, pause fuel sales
-
Springboks recall 'outstanding' Papier for Nations Championship
-
US, Iran set for talks as Lebanon conflict threatens deal
-
Bezzecchi out of Czech MotoGP after slapping steward
-
Spain target convincing win to dispel World Cup doubts
-
FIFA draws criticism as Infantino clocks up air miles at World Cup
-
Curacao keeper Room jokes he deserves statue after World Cup heroics
-
Japan stroll to victory over Tunisia in World Cup's 1,000th game
-
Pakistan's mango exports shrink as Middle East war impacts linger
-
Trump blames 'terrible vandals' for Washington pool renovation woes
-
Iran World Cup travel restrictions to be eased, says coach
-
Man charged over suspected anti-Muslim attacks in Edinburgh
-
Room heroics earn Curacao World Cup point against Ecuador
-
Britain's King Charles to reveal personal tax bill: reports
-
New mindset, prior win give Clark confidence at US Open
Reminder - Webcast/Conference Call to Discuss Fantastic PRIME Phase 1b Top-line Data
SAN DIEGO, CA / ACCESS Newswire / September 9, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company focused on rebalancing inflammation, wants to remind you of our September 10th webcast at 8:30 am Eastern Time, which can be accessed here or to call in, please dial 888-506-0062 (toll free in the US), +1 973-528-0011 (if International) and use the participant access code 289672. We look forward to reviewing the data with you tomorrow morning.
A copy of the original press release announcing data can be found here.
A copy of the presentation to be reviewed can be found here.
About Revelation Biosciences, Inc.
Revelation Biosciences, Inc. is a clinical stage life sciences company focused on rebalancing inflammation using its proprietary formulation Gemini. Revelation has multiple ongoing programs to evaluate Gemini, including as a prevention for post-surgical infection, as prevention for acute kidney injury and the treatment of chronic kidney disease.
For more information on Revelation, please visit https://www.revbiosciences.com.
Company Contact
Mike Porter
Investor Relations
Porter LaVay & Rose Inc.
Email: [email protected]
Chester Zygmont, III
Chief Financial Officer
Revelation Biosciences Inc.
Email: [email protected]
SOURCE: Revelation Biosciences, Inc.
View the original press release on ACCESS Newswire
G.P.Martin--AT
